4.4 Article

Assessment of Structural Lesions in Sacroiliac Joints Enhances Diagnostic Utility of Magnetic Resonance Imaging in Early Spondylarthritis

Journal

ARTHRITIS CARE & RESEARCH
Volume 62, Issue 12, Pages 1763-1771

Publisher

WILEY-LISS
DOI: 10.1002/acr.20312

Keywords

-

Categories

Funding

  1. Canadian Arthritis Society National Research Initiative
  2. Alberta Heritage Foundation for Medical Research
  3. Walter L. and Johanna Wolf Foundation, Zurich, Switzerland
  4. Foundation for Scientific Research at the University of Zurich, Zurich, Switzerland

Ask authors/readers for more resources

Objective. To compare the diagnostic utility of T1-weighted and STIR magnetic resonance imaging (MRI) sequences in early spondylarthritis (SpA) using a standardized approach to the evaluation of sacroiliac (SI) joints, and to test whether systematic calibration of readers directed at recognition of abnormalities on T1-weighted MRI would enhance diagnostic utility. Methods. Six readers independently assessed T1-weighted and STIR MRI scans of the SI joints from 187 subjects: 75 ankylosing spondylitis (AS) and 27 preradiographic inflammatory back pain (IBP) patients, and 26 mechanical back pain and 59 healthy volunteer controls ages <= 45 years. The exercise was repeated 6 months later on a random selection of 30 AS patients and 34 controls after calibration directed at lesions visible on T1-weighted MRI. Specific MRI lesions were recorded according to standardized definitions. In addition to deciding on the presence/absence of SpA, readers were asked which MRI sequence and which type of lesion was the primary basis for their diagnostic conclusion. Results. Structural lesions were detected in 98% of AS patients and 64% of IBP patients. A diagnosis of SpA was based on T1-weighted or combined T1-weighted/STIR sequences in 82% of AS patients and 41% of IBP patients. Calibration enhanced the diagnostic utility of MRI in the majority of readers, especially those considered less experienced; the mean positive and negative likelihood ratios (of 6 readers) were 14.5 and 0.08 precalibration, respectively, and 22.2 and 0.02 postcalibration, respectively. Conclusion. Recognition of structural lesions on T1-weighted MRI contributes significantly to its diagnostic utility in early SpA. Rheumatologist training directed at detection of lesions visible on T1-weighted MRI enhances diagnostic utility.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Response to: 'Correspondence on 'MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group'' by Jibri et al

Walter P. Maksymowych, Robert G. W. Lambert, Mikkel ostergaard, Xenofon Baraliakos

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years

Desiree van der Heijde, Mikkel Ostergaard, John D. Reveille, Xenofon Baraliakos, Andris Kronbergs, David M. Sandoval, Xiaoqi Li, Hilde Carlier, David H. Adams, Walter P. Maksymowych

Summary: This study evaluates the long-term effect of IXE on radiographic changes in the spine in patients with r-axSpA and identifies potential predictors of progression. The majority of patients had no radiographic progression in the spine through 2 years of treatment.

JOURNAL OF RHEUMATOLOGY (2022)

Review Rheumatology

A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition

Iain B. McInnes, Zoltan Szekanecz, Dennis McGonagle, Walter P. Maksymowych, Alexander Pfeil, Ralph Lippe, In-Ho Song, Apinya Lertratanakul, Thierry Sornasse, Ana Biljan, Atul Deodhar

Summary: Spondyloarthritis (SpA) is a group of chronic inflammatory diseases characterized by overlapping clinical, genetic and pathophysiological features. Various cytokines are involved in the pathogenesis of SpA, and inhibition of the JAK signaling pathway can suppress SpA development. This article discusses the role of JAK signaling in the pathogenesis of SpA and summarizes the safety and efficacy of JAK inhibition based on relevant clinical trials.

RHEUMATOLOGY (2022)

Article Rheumatology

Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial

Walter P. Maksymowych, Mikkel Ostergaard, Robert Landewe, William Barchuk, Ke Liu, Leen Gilles, Thijs Hendrikx, Robin Besuyen, Xenofon Baraliakos

Summary: The study showed that filgotinib treatment was associated with significant reductions in spinal inflammation, suggesting potential therapeutic benefits for patients with active ankylosing spondylitis.

RHEUMATOLOGY (2022)

Article Rheumatology

MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group

Xenofon Baraliakos, Mikkel Ostergaard, Robert G. W. Lambert, Iris Eshed, Pedro M. Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Desiree van der Heijde, Robert B. M. Landewe, Walter Maksymowych

Summary: This study updated and validated the definitions of spinal MRI lesions associated with axial spondyloarthritis (axSpA), focusing on inflammatory and structural lesions in terms of localization, extension, and extent, with new classifications based on lesion maturity. The reliability assessment confirmed VC fat lesion and VC monomorphic inflammatory lesion as the most reliably assessed lesions.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

What Constitutes a Positive MRI for Clinical Trial Recruitment of Psoriatic Arthritis Patients With Axial Involvement?

Walter P. Maksymowych, Mikkel Ostergaard

Summary: There is a renewed interest in defining the axial inflammation component of Psoriatic Arthritis (PsA), as recent studies suggest that this entity may respond differently to treatment compared to patients with axial spondyloarthritis. A workshop was conducted to review the literature on diagnosing PsA and to determine the most appropriate criteria. It was widely agreed that magnetic resonance imaging (MRI) plays an important role in defining axial inflammation in PsA, and it would be ideal to establish optimal MRI quantitative cut-offs for lesions in the sacroiliac joints and/or spine that reflect imaging typical of axial inflammation in PsA.

JOURNAL OF RHEUMATOLOGY (2022)

Article Rheumatology

Improving the design of RCTs in non-radiographic axial spondyloarthritis

Walter P. Maksymowych, Robert G. W. Lambert, Liron Caplan, Filip E. van den Bosch, Mikkel ostergaard

Summary: The current RCT design does not fully utilize MRI to select nr-axSpA patients who best demonstrate differences in clinical response rates between active drug and placebo therapies. Future studies should incorporate revised patient inclusion criteria based on expanded MRI evaluation and data-driven definitions of a positive MRI to improve discrimination between therapies.

NATURE REVIEWS RHEUMATOLOGY (2022)

Article Rheumatology

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

Desiree van der Heijde, Lianne S. Gensler, Walter P. Maksymowych, Robert Landewe, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul Deodhar

Summary: The 52-week results from the C-axSpAnd study demonstrate the long-term safety and efficacy of Certolizumab pegol (CZP) in patients with active non-radiographic axial spondyloarthritis (nr-axSpA). CZP treatment for up to 3 years is well tolerated and leads to sustained clinical improvement.

RMD OPEN (2022)

Article Rheumatology

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

Victoria Navarro-Compan, Anne Boel, Annelies Boonen, Philip J. Mease, Maxime Dougados, Uta Kiltz, Robert B. M. Landewe, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Yu Heng Kwan, Pedro M. Machado, Walter Maksymowych, Anna Molto, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Sofia Ramiro, In-Ho Song, Salima van Weely, Desiree van der Heijde

Summary: This study aims to define the instruments for the Assessment of SpondyloArthritis international Society-Outcomes Measures in Rheumatology core domain set for axial spondyloarthritis (axSpA). The study selected core outcome instruments through a systematic literature review and assessment of the instruments' psychometric properties. Additionally, the study endorsed additional instruments to enhance the evaluation of axSpA trials.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort

Mikhail Protopopov, Fabian Proft, Stephanie Wichuk, Pedro M. Machado, Robert G. Lambert, Ulrich Weber, Susanne Juhl Pedersen, Mikkel Ostergaard, Joachim Sieper, Martin Rudwaleit, Xenofon Baraliakos, Walter P. Maksymowych, Denis Poddubnyy

Summary: This study compares the ability of MRI and conventional radiography to detect structural lesions indicative of axSpA.

RHEUMATOLOGY (2023)

Review Rheumatology

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Ying-Ying Leung, Tatiana V. Korotaeva, Liliana Candia, Susanne Juhl Pedersen, Wilson Bautista Molano, Eric M. Ruderman, Radjesh Bisoendial, Rodolfo Perez-Alamino, Wendy Olsder, Burkhard Moeller, Simeon Grazio, Tania Gudu, Girish M. Mody, Carlos Pineda, Helena Raffayova, Sherry Rohekar, Claudia Goldenstein-Schainberg, Sergio R. Gutierrez Urena, Julio Cesar Casasola Vargas, Bhowmik Meghnathi, Roopa Prasad, Pascal Richette, Jose Roberto S. Miranda, Nikolas Malliotis, Ulla Lindqvist, David Simon, Amara Ezeonyeli, Enrique R. Soriano, Oliver FitzGerald

Summary: The objective of this study was to provide evidence for the efficacy and safety of therapeutic options for the peripheral arthritis domain of PsA for the revised 2021 GRAPPA treatment recommendations. Evidence was derived from new RCTs and recommendations were made for different patient groups based on their treatment history and response. Different classes of therapeutic options were strongly recommended for different patient groups.

JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis-results from two randomized controlled trials

Helena Port, Signe Holm Nielsen, Peder Frederiksen, Sofie Falkenlove Madsen, Anne-Christine Bay-Jensen, Inge Juul Sorensen, Bente Jensen, Anne Gitte Loft, Ole Rintek Madsen, Mikkel Ostergaard, Susanne Juhl Pedersen

Summary: This study investigated whether extracellular matrix (ECM) blood-based biomarkers reflect the pharmacodynamic effect and response to TNF-a inhibitor therapy in patients with axial spondyloarthritis (axSpA). The results showed that ECM metabolites exhibited a pharmacodynamic effect and were associated with ASDAS response.

ARTHRITIS RESEARCH & THERAPY (2023)

Article Rheumatology

Comparative validation of the knee inflammation MRI scoring system and the MRI osteoarthritis knee score for semi-quantitative assessment of bone marrow lesions and synovitis-effusion in osteoarthritis: an international multi-reader exercise

Walter P. Maksymowych, Jacob L. Jaremko, Susanne J. Pedersen, Iris Eshed, Ulrich Weber, Andrew McReynolds, Paul Bird, Stephanie Wichuk, Robert G. Lambert

Summary: This study compared the performance of two new web-based MRI scoring systems (KIMRISS and MOAKS) in quantification of bone marrow lesions (BML) and synovitis-effusion (S-E). The results showed that KIMRISS had higher reliability and usability in evaluating BML and synovitis. Both methods should be further compared in clinical trials of new therapies for OA.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

Article Rheumatology

Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy

Signe Holm Nielsen, Shu Sun, Anne C. Bay-Jensen, Morten Karsdal, Inge Juul Sorensen, Ulrich Weber, Anne Gitte Loft, Gina Kollerup, Gorm Thamsborg, Ole Rintek Madsen, Jakob Moller, Mikkel Ostergaard, Susanne Juhl Pedersen

Summary: This study investigated the association of extracellular matrix (ECM) metabolites with treatment response in axSpA patients receiving TNF-alpha inhibitory therapy. The results showed that certain ECM metabolites were associated with ASDAS response, MRI inflammation, and clinical treatment response.

ARTHRITIS RESEARCH & THERAPY (2022)

Article Rheumatology

Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain

Helena Port, Signe Holm Nielsen, Sofie Falkenlove Madsen, Anne-Christine Bay-Jensen, Morten Karsdal, Sengul Seven, Inge Juul Sorensen, Lone Morsel-Carlsen, Mikkel Ostergaard, Susanne Juhl Pedersen

Summary: This study investigated circulating biomarkers of extracellular matrix (ECM) remodeling and inflammation as potential markers to identify patients with axial spondyloarthritis (axSpA). The results showed that axSpA patients had altered turnover of type I, IV, and VI collagens compared to non-axSpA control groups. The biomarker PRO-C4 was found to be the best indicator for differentiating axSpA patients from non-axSpA subjects.

ARTHRITIS RESEARCH & THERAPY (2022)

No Data Available